Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 180-185, July 2007

Commentary on “Health economics and the value of therapy in Alzheimer’s disease.” Drug treatment of Alzheimer’s disease: The United Kingdom experience—National Institute for Health and Clinical Excellence guidance and guidelines for dementia

  • Roy Jones

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-(0)-1225-835866; Fax: +44-(0)-1225-840395.

Research Institute for the Care of the Elderly, St Martin’s Hospital, and School for Health, University of Bath, Bath, United Kingdom

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1552-5260(07)00480-3

doi:10.1016/j.jalz.2007.04.386

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 180-185, July 2007

Article Tools